XML 52 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Valuation (Tables)
12 Months Ended
Dec. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule Of Financial Instruments
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2017:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
26,500

 
$

 
$

 
$
26,500

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
989,341

 
$
6,173

 
$
995,514

Private label residential mortgage-backed securities
 

 
158,369

 
101,297

 
259,666

Private label commercial mortgage-backed securities
 

 
28,398

 
12,347

 
40,745

Commercial mortgage loans
 

 

 
108,301

 
108,301

Residential mortgage loans
 

 

 
182,472

 
182,472

Collateralized loan obligations
 

 
185,905

 
24,911

 
210,816

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
135,258

 
135,258

Corporate debt
 

 
51,246

 
23,947

 
75,193

Real estate owned
 

 

 
26,277

 
26,277

Corporate equity investments
 

 

 
37,465

 
37,465

Total investments, at fair value
 

 
1,413,259

 
658,448

 
2,071,707

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
3,140

 
3,140

Credit default swaps on corporate bond indices
 

 
1,429

 

 
1,429

Credit default swaps on corporate bonds
 

 
8,888

 

 
8,888

Credit default swaps on asset-backed indices
 

 
5,393

 

 
5,393

Interest rate swaps
 

 
9,266

 

 
9,266

Options
 
3

 
1

 

 
4

Futures
 
45

 

 

 
45

Total financial derivatives–assets, at fair value
 
48

 
24,977

 
3,140

 
28,165

Repurchase agreements, at fair value
 

 
155,949

 

 
155,949

Total investments, financial derivatives–assets, and repurchase agreements, at fair value
 
$
48

 
$
1,594,185

 
$
661,588

 
$
2,255,821

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(460,189
)
 
$

 
$
(460,189
)
Government debt
 

 
(90,149
)
 

 
(90,149
)
Corporate debt
 

 
(55,211
)
 

 
(55,211
)
Common stock
 
(36,691
)
 

 

 
(36,691
)
Total investments sold short, at fair value
 
(36,691
)
 
(605,549
)
 

 
(642,240
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 
$

 
$
(12,367
)
 
$

 
$
(12,367
)
Credit default swaps on corporate bonds
 

 
(15,930
)
 

 
(15,930
)
Credit default swaps on asset-backed indices
 

 
(980
)
 

 
(980
)
Interest rate swaps
 

 
(6,015
)
 

 
(6,015
)
Futures
 
(508
)
 

 

 
(508
)
Forwards
 

 
(473
)
 

 
(473
)
Total financial derivatives–liabilities, at fair value
 
(508
)
 
(35,765
)
 

 
(36,273
)
Other secured borrowings, at fair value
 
$

 
$

 
$
(125,105
)
 
$
(125,105
)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value
 
$
(37,199
)
 
$
(641,314
)
 
$
(125,105
)
 
$
(803,618
)

The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2016:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
90,000

 
$

 
$

 
$
90,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
868,345

 
$
29,622

 
$
897,967

U.S. Treasury securities
 

 
5,419

 

 
5,419

Private label residential mortgage-backed securities
 

 
53,525

 
90,083

 
143,608

Private label commercial mortgage-backed securities
 

 

 
43,268

 
43,268

Commercial mortgage loans
 

 

 
61,129

 
61,129

Residential mortgage loans
 

 

 
84,290

 
84,290

Collateralized loan obligations
 

 

 
44,956

 
44,956

Consumer loans and asset-backed securities backed by consumer loans(1)
 

 

 
107,157

 
107,157

Corporate debt
 

 
55,091

 
25,004

 
80,095

Real estate owned
 

 

 
3,349

 
3,349

Corporate equity investments(1)
 
4,396

 

 
29,392

 
33,788

Total investments, at fair value
 
4,396

 
982,380

 
518,250

 
1,505,026

 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 
$

 
$

 
$
5,326

 
$
5,326

Credit default swaps on corporate bond indices
 

 
2,744

 

 
2,744

Credit default swaps on corporate bonds
 

 
2,360

 

 
2,360

Credit default swaps on asset-backed indices
 

 
16,713

 

 
16,713

Interest rate swaps
 

 
8,102

 

 
8,102

Total return swaps
 

 

 
155

 
155

Options
 
42

 
2

 

 
44

Futures
 
29

 

 

 
29

Forwards
 

 
16

 

 
16

Warrants
 

 

 
106

 
106

Total financial derivatives–assets, at fair value
 
71

 
29,937

 
5,587

 
35,595

Repurchase agreements, at fair value
 

 
184,819

 

 
184,819

Total investments, financial derivatives–assets, and repurchase agreements, at fair value
 
$
4,467

 
$
1,197,136

 
$
523,837

 
$
1,725,440

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(404,728
)
 
$

 
$
(404,728
)
Government debt
 

 
(132,442
)
 

 
(132,442
)
Corporate debt
 

 
(39,572
)
 

 
(39,572
)
Common stock
 
(8,154
)
 

 

 
(8,154
)
Total investments sold short, at fair value
 
(8,154
)
 
(576,742
)
 

 
(584,896
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(2,840
)
 

 
(2,840
)
Credit default swaps on corporate bonds
 

 
(6,654
)
 

 
(6,654
)
Credit default swaps on asset-backed indices
 

 
(2,899
)
 

 
(2,899
)
Credit default swaps on asset-backed securities
 

 

 
(256
)
 
(256
)
Interest rate swaps
 

 
(5,162
)
 

 
(5,162
)
Total return swaps
 

 
(55
)
 
(249
)
 
(304
)
Futures
 
(69
)
 

 

 
(69
)
Forwards
 

 
(472
)
 

 
(472
)
Mortgage loan purchase commitments
 

 
(31
)
 

 
(31
)
Total financial derivatives–liabilities, at fair value
 
(69
)
 
(18,113
)
 
(505
)
 
(18,687
)
Total investments sold short and financial derivatives–liabilities, at fair value
 
$
(8,223
)
 
$
(594,855
)
 
$
(505
)
 
$
(603,583
)
Schedule Of Significant Unobservable Inputs, Qualitative Information
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2017:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
40,870

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
45.00

 
$
183.00

 
$
81.63

Collateralized loan obligations
 
10,288

 
Market Quotes
 
Non Binding Third-Party Valuation
 
85.00

 
435.00

 
138.94

Corporate debt and non-exchange traded corporate equity
 
6,797

 
Market Quotes
 
Non Binding Third-Party Valuation
 
8.88

 
105.63

 
82.94

Private label commercial mortgage-backed securities
 
7,577

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.31

 
60.55

 
36.19

Agency interest only residential mortgage-backed securities
 
1,225

 
Market Quotes
 
Non Binding Third-Party Valuation
 
10.14

 
18.21

 
15.25

Private label residential mortgage-backed securities
 
60,427

 
Discounted Cash Flows
 
Yield
 
0.5
%
 
26.5
%
 
9.8
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
2.1
%
 
84.7
%
 
38.3
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
18.2
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
31.5
%
 
11.3
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
12.5
%
 
90.2
%
 
41.8
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
4,770

 
Discounted Cash Flows
 
Yield
 
4.3
%
 
42.5
%
 
18.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.1
%
 
5.2
%
 
2.5
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
2.8
%
 
17.1
%
 
8.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
80.1
%
 
96.1
%
 
89.0
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and non-exchange traded corporate equity
 
20,301

 
Discounted Cash Flows
 
Yield
 
3.0
%
 
16.1
%
 
10.6
%
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Collateralized loan obligations
 
$
14,623

 
Discounted Cash Flows
 
Yield
 
7.1
%
 
62.2
%
 
15.2
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
22.5
%
 
92.9
%
 
77.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.9
%
 
40.2
%
 
10.3
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
3.4
%
 
37.2
%
 
9.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
%
 
4.1
%
 
2.3
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
 
135,258

 
Discounted Cash Flows
 
Yield
 
7.0
%
 
18.9
%
 
9.5
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
2.2
%
 
50.1
%
 
33.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.4
%
 
28.6
%
 
8.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
46.8
%
 
95.2
%
 
58.3
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
84,377

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
15.4
%
 
10.7
%
Non-performing commercial mortgage loans and commercial real estate owned
 
49,610

 
Discounted Cash Flows
 
Yield
 
11.4
%
 
36.5
%
 
17.7
%
 
 
 
 
 
 
Months to Resolution
 
4.0

 
17.0

 
9.5

Performing residential mortgage loans
 
42,030

 
Discounted Cash Flows
 
Yield
 
1.6
%
 
18.8
%
 
6.2
%
Securitized residential mortgage loans(1)
 
132,424

 
Discounted Cash Flows
 
Yield
 
3.5
%
 
3.5
%
 
3.5
%
Non-performing residential mortgage loans and residential real estate owned
 
8,609

 
Discounted Cash Flows
 
Yield
 
2.8
%
 
34.5
%
 
8.9
%
 
 
 
 
 
 
Months to Resolution(2)
 
1.9

 
40.5

 
25.6

Credit default swaps on asset-backed securities
 
3,140

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.8
%
 
26.5
%
 
22.4
%
 
 
 
 
 
 
Projected Collateral Losses
 
14.6
%
 
23.8
%
 
19.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
5.8
%
 
14.3
%
 
10.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
45.5
%
 
51.0
%
 
47.3
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Agency interest only residential mortgage-backed securities
 
4,948

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
381

 
3,521

 
730

 
 
 
 
 
 
Projected Collateral Prepayments
 
51.2
%
 
100.0
%
 
69.1
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
48.8
%
 
30.9
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded common equity investment in mortgage-related entity
 
2,814

 
Enterprise Value
 
Equity Price-to-Book(4)
 
2.0x
 
2.0x
 
2.0x
Non-exchange traded preferred equity investment in mortgage-related entity
 
20,774

 
Enterprise Value
 
Equity Price-to-Book(4)
 
0.9x
 
0.9x
 
0.9x
Non-controlling equity interest in limited liability company
 
5,033

 
Market Quotes
 
Non Binding Third-Party Valuation of the Underlying Assets(5)
 
$
96.91

 
$
96.91

 
$
96.91

Non-controlling equity interest in limited liability company
 
5,693

 
Discounted Cash Flows
 
Yield(5)
 
9.1%
 
9.1%
 
9.1%
Other secured borrowings, at fair value(1)
 
(125,105
)
 
Discounted Cash Flows
 
Yield
 
2.8%
 
2.8%
 
2.8%

(1)
Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.
(2)
Excludes certain loans that are re-performing.
(3)
Shown in basis points.
(4)
Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(5)
Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2016:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
47,024

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
2.00

 
$
101.02

 
$
67.51

Collateralized loan obligations
 
37,517

 
Market Quotes
 
Non Binding Third-Party Valuation
 
9.42

 
100.25

 
83.36

Corporate debt and non-exchange traded corporate equity
 
19,017

 
Market Quotes
 
Non Binding Third-Party Valuation
 
1.88

 
102.25

 
87.14

Private label commercial mortgage-backed securities
 
27,283

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.17

 
77.75

 
40.88

Agency interest only residential mortgage-backed securities
 
23,322

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.47

 
20.17

 
11.65

Total return swaps
 
(94
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1)
 
98.25

 
99.50

 
98.77

Private label residential mortgage-backed securities
 
43,059

 
Discounted Cash Flows
 
Yield
 
0.6
%
 
20.5
%
 
11.0
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
81.0
%
 
10.0
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.4
%
 
51.2
%
 
41.4
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.4
%
 
53.6
%
 
41.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.7
%
 
7.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
15,985

 
Discounted Cash Flows
 
Yield
 
8.8
%
 
57.0
%
 
23.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.1
%
 
5.3
%
 
2.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.9
%
 
20.5
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
77.8
%
 
99.0
%
 
87.1
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
 
10,080

 
Discounted Cash Flows
 
Yield
 
19.7
%
 
19.7
%
 
19.7
%
Collateralized loan obligations
 
7,439

 
Discounted Cash Flows
 
Yield
 
11.2
%
 
50.3
%
 
20.5
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
11.4
%
 
55.2
%
 
45.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
4.5
%
 
28.3
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
27.2
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
29.8
%
 
51.5
%
 
35.2
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans(2)
 
107,157

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
25.0
%
 
11.0
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
45.4
%
 
25.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
3.3
%
 
97.4
%
 
9.4
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
87.7
%
 
65.0
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
32,557

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
17.2
%
 
11.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Non-performing commercial mortgage loans and commercial real estate owned
 
$
30,222

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
27.8
%
 
16.3
%
 
 
 
 
 
 
Months to Resolution
 
3.0

 
39.1

 
19.5

Performing residential mortgage loans
 
78,576

 
Discounted Cash Flows
 
Yield
 
5.0
%
 
13.5
%
 
6.6
%
Non-performing residential mortgage loans and residential real estate owned
 
7,413

 
Discounted Cash Flows
 
Yield
 
5.8
%
 
39.9
%
 
9.7
%
 
 
 
 
 
 
Months to Resolution
 
1.8

 
162.9

 
41.9

Credit default swaps on asset-backed securities
 
5,070

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.3
%
 
29.8
%
 
22.7
%
 
 
 
 
 
 
Projected Collateral Losses
 
15.3
%
 
27.6
%
 
22.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
4.7
%
 
15.3
%
 
8.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
43.2
%
 
50.2
%
 
46.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
 
3,090

 
Discounted Cash Flows
 
Yield
 
16.5
%
 
16.5
%
 
16.5
%
 
 
 
 
 
 
Expected Holding Period (Months)
 
2.9

 
2.9

 
2.9

Agency interest only residential mortgage-backed securities
 
6,300

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
142

 
2,831

 
568

 
 
 
 
 
 
Projected Collateral Prepayments(2)
 
0.0
%
 
100.0
%
 
63.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
88.1
%
 
36.4
%
 
 


 
 
 
 
 
 
 


 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entity
 
2,500

 
Enterprise Value
 
Equity Price-to-Book(4)
 
1.3x

 
1.3x

 
1.3x

Non-controlling equity interest in limited liability company(2)
 
7,315

 
Net Discounted Cash Flows
 
Yield
 
8.5
%
 
8.5
%
 
8.5
%
Non-exchange traded preferred equity investment in mortgage-related entity
 
12,500

 
Recent Transactions
 
Transaction Price
 
N/A

 
N/A

 
N/A

(1)
Represents valuations on underlying assets.
(2)
Conformed to current period presentation.
(3)
Shown in basis points.
(4)
Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
Fair Value Measurement Using Significant Unobservable Inputs
The tables below include a roll-forward of the Company's financial instruments for the years ended December 31, 2017, 2016, and 2015 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Year Ended December 31, 2017
(In thousands)
Ending
Balance as of 
December 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
December 31, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
29,622

 
$
(9,356
)
 
$
(956
)
 
$
(165
)
 
$
3,867

 
$
(153
)
 
$

 
$
(16,686
)
 
$
6,173

Private label residential mortgage-backed securities
90,083

 
2,203

 
763

 
9,498

 
68,724

 
(54,690
)
 
14,021

 
(29,305
)
 
101,297

Private label commercial mortgage-backed securities
43,268

 
469

 
(3,596
)
 
8,654

 
6,661

 
(37,665
)
 

 
(5,444
)
 
12,347

Commercial mortgage loans
61,129

 
921

 
419

 
1,957

 
78,333

 
(34,458
)
 

 

 
108,301

Residential mortgage loans
84,290

 
(599
)
 
1,602

 
3,536

 
140,535

 
(46,892
)
 

 

 
182,472

Collateralized loan obligations
44,956

 
(6,833
)
 
2,233

 
2,606

 
71,338

 
(76,775
)
 

 
(12,614
)
 
24,911

Consumer loans and asset-backed securities backed by consumer loans
107,157

 
(13,754
)
 
855

 
(171
)
 
129,525

 
(88,354
)
 

 

 
135,258

Corporate debt
25,004

 
252

 
527

 
223

 
97,466

 
(99,525
)
 

 

 
23,947

Real estate owned
3,349

 

 
411

 
322

 
25,516

 
(3,321
)
 

 

 
26,277

Corporate equity investments
29,392

 

 
2,347

 
(512
)
 
16,417

 
(10,179
)
 

 

 
37,465

Total investments, at fair value
518,250

 
(26,697
)
 
4,605

 
25,948

 
638,382

 
(452,012
)
 
14,021

 
(64,049
)
 
658,448

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,326

 

 
270

 
(1,202
)
 
137

 
(1,391
)
 

 

 
3,140

Total return swaps
155

 

 
224

 
(155
)
 
1

 
(225
)
 

 

 

Warrants
106

 

 
(100
)
 
(6
)
 

 

 

 

 

Total financial derivatives– assets, at fair value
5,587

 

 
394

 
(1,363
)
 
138

 
(1,616
)
 

 

 
3,140

Total investments and financial derivatives–assets, at fair value
$
523,837

 
$
(26,697
)
 
$
4,999

 
$
24,585

 
$
638,520

 
$
(453,628
)
 
$
14,021

 
$
(64,049
)
 
$
661,588

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
December 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
December 31, 2017
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(256
)
 
$

 
$
(871
)
 
$
939

 
$
736

 
$
(548
)
 
$

 
$

 
$

Total return swaps
(249
)
 

 
(554
)
 
249

 
572

 
(18
)
 

 

 

Total financial derivatives– liabilities, at fair value
(505
)
 

 
(1,425
)
 
1,188

 
1,308

 
(566
)
 

 

 

Other secured borrowings, at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other secured borrowings, at fair value

 

 

 

 

 
(125,105
)
 

 

 
(125,105
)
Total other secured borrowings, at fair value

 

 

 

 

 
(125,105
)
 

 

 
(125,105
)
Total financial derivatives– liabilities and other secured borrowings at fair value
$
(505
)
 
$

 
$
(1,425
)
 
$
1,188

 
$
1,308

 
$
(125,671
)
 
$

 
$

 
$
(125,105
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2017, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2017. For Level 3 financial instruments held by the Company at December 31, 2017, change in net unrealized gain (loss) of $10.6 million and $(1.2) million for the year ended December 31, 2017 relate to investments and financial derivatives–assets, respectively.
As of June 30, 2017, the Company modified its procedures to determine the level within the hierarchy for certain financial instruments. Under the revised procedure, the Company examines financial instruments individually rather than in cohorts of like instruments as it had previously. As of December 31, 2017, the Company transferred $64.0 million of securities from Level 3 to Level 2 and $14.0 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.
Year Ended December 31, 2016
(In thousands)
Ending
Balance as of December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
December 31, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
24,918

 
$
(7,998
)
 
$
(536
)
 
$
845

 
$
12,665

 
$
(272
)
 
$

 
$

 
$
29,622

Private label residential mortgage-backed securities
116,435

 
1,896

 
(2,748
)
 
3,972

 
30,065

 
(55,407
)
 
10,041

 
(14,171
)
 
90,083

Private label commercial mortgage-backed securities
34,145

 
1,627

 
1,008

 
(6,081
)
 
24,488

 
(11,919
)
 

 

 
43,268

Commercial mortgage loans
66,399

 
2,463

 
1,920

 
(1,434
)
 
39,684

 
(47,903
)
 

 

 
61,129

Residential mortgage loans
22,089

 
467

 
774

 
(800
)
 
102,224

 
(40,464
)
 

 

 
84,290

Collateralized loan obligations
45,974

 
(3,829
)
 
71

 
2,471

 
27,862

 
(27,593
)
 

 

 
44,956

Consumer loans and asset-backed securities backed by consumer loans(1)
115,376

 
(10,668
)
 
(164
)
 
(3,711
)
 
154,101

 
(147,777
)
 

 

 
107,157

Corporate debt
27,028

 
(60
)
 
(8,326
)
 
6,864

 
26,851

 
(27,353
)
 

 

 
25,004

Real estate owned
12,522

 

 
2,256

 
(458
)
 
17,526

 
(28,497
)
 

 

 
3,349

Corporate equity investments(1)
22,088

 

 
(144
)
 
(3,075
)
 
44,680

 
(34,157
)
 

 

 
29,392

Total investments, at fair value
486,974

 
(16,102
)
 
(5,889
)
 
(1,407
)
 
480,146

 
(421,342
)
 
10,041

 
(14,171
)
 
518,250

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,332

 

 
1,042

 
(667
)
 
148

 
(1,529
)
 

 

 
5,326

Total return swaps
85

 

 
3,070

 
70

 
57

 
(3,127
)
 

 

 
155

Warrants
150

 

 
(50
)
 
6

 
7,486

 
(7,486
)
 

 

 
106

Total financial derivatives– assets, at fair value
6,567

 

 
4,062

 
(591
)
 
7,691

 
(12,142
)
 

 

 
5,587

Total investments and financial derivatives–assets, at fair value
$
493,541

 
$
(16,102
)
 
$
(1,827
)
 
$
(1,998
)
 
$
487,837

 
$
(433,484
)
 
$
10,041

 
$
(14,171
)
 
$
523,837

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(448
)
 
$
(1
)
 
$
362

 
$
(228
)
 
$
315

 
$

 
$

 
$

 
$

Total investments sold short, at fair value
(448
)
 
(1
)
 
362

 
(228
)
 
315

 

 

 

 

Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
(221
)
 

 
(323
)
 
(36
)
 
324

 

 

 

 
(256
)
Total return swaps
(4,662
)
 

 
(7,534
)
 
4,413

 
8,214

 
(680
)
 

 

 
(249
)
Total financial derivatives– liabilities, at fair value
(4,883
)
 

 
(7,857
)
 
4,377

 
8,538

 
(680
)
 

 

 
(505
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(828
)
 

 

 
828

 

 

 

 

 

Total guarantees
(828
)
 

 

 
828

 

 

 

 

 

Total investments sold short, financial derivatives–liabilities, and guarantees, at fair value
$
(6,159
)
 
$
(1
)
 
$
(7,495
)
 
$
4,977

 
$
8,853

 
$
(680
)
 
$

 
$

 
$
(505
)

(1)
Conformed to current period presentation.
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2016, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2016. For Level 3 financial instruments held by the Company at December 31, 2016, change in net unrealized gain (loss) of $(14.7) million, $(0.8) million, and $(0.2) million, for the year ended December 31, 2016 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively.
As of December 31, 2016, the Company transferred $14.2 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view.
In addition, as of December 31, 2016, the Company transferred $10.0 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2015, these securities exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities.
Year Ended December 31, 2015
(In thousands)
Ending
Balance as of December 31, 2014
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
December 31, 2015
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
31,385

 
$
(8,355
)
 
$
223

 
$
81

 
$
6,977

 
$
(5,393
)
 
$

 
$

 
$
24,918

Private label residential mortgage-backed securities
274,369

 
8,593

 
20,648

 
(16,429
)
 
62,994

 
(191,902
)
 
6,687

 
(48,525
)
 
116,435

Private label commercial mortgage-backed securities
53,311

 
3,076

 
2,000

 
(4,183
)
 
21,382

 
(41,441
)
 

 

 
34,145

Commercial mortgage loans
28,309

 
1,895

 
1,114

 
(142
)
 
69,778

 
(34,555
)
 

 

 
66,399

Residential mortgage loans
27,482

 
1,363

 
2,372

 
(505
)
 
19,555

 
(28,178
)
 

 

 
22,089

Collateralized loan obligations
121,994

 
(21,110
)
 
46

 
(4,033
)
 
59,102

 
(110,025
)
 

 

 
45,974

Consumer loans and asset-backed securities backed by consumer loans
24,294

 
(6,197
)
 

 
283

 
139,373

 
(42,377
)
 

 

 
115,376

Corporate debt
42,708

 
60

 
(4,028
)
 
(6,882
)
 
28,942

 
(33,772
)
 

 

 
27,028

Real estate owned
8,635

 

 
1,168

 
381

 
14,155

 
(11,817
)
 

 

 
12,522

Private corporate equity investments
14,512

 

 
116

 
(306
)
 
8,347

 
(581
)
 

 

 
22,088

Total investments, at fair value
626,999

 
(20,675
)
 
23,659

 
(31,735
)
 
430,605

 
(500,041
)
 
6,687

 
(48,525
)
 
486,974

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
11,387

 
$

 
$
(2,964
)
 
$
2,098

 
$
28

 
$
(4,217
)
 
$

 
$

 
$
6,332

Total return swaps

 

 
113

 
85

 

 
(113
)
 

 

 
85

Warrants
100

 

 

 

 
50

 

 

 

 
150

Total financial derivatives– assets, at fair value
11,487

 

 
(2,851
)
 
2,183

 
78

 
(4,330
)
 

 

 
6,567

Total investments and financial derivatives–assets, at fair value
$
638,486

 
$
(20,675
)
 
$
20,808

 
$
(29,552
)
 
$
430,683

 
$
(504,371
)
 
$
6,687

 
$
(48,525
)
 
$
493,541

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of December 31, 2014
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
December 31, 2015
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$

 
$
(2
)
 
$
197

 
$
228

 
$
1,372

 
$
(2,243
)
 
$

 
$

 
$
(448
)
Total investments sold short, at fair value

 
(2
)
 
197

 
228

 
1,372

 
(2,243
)
 

 

 
(448
)
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(239
)
 
$

 
$
(102
)
 
$
35

 
$

 
$
85

 
$

 
$

 
$
(221
)
Total return swaps

 

 
2,516

 
(4,662
)
 
14

 
(2,530
)
 

 

 
(4,662
)
Total financial derivatives– liabilities, at fair value
(239
)
 

 
2,414

 
(4,627
)
 
14

 
(2,445
)
 

 

 
(4,883
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(774
)
 
(15
)
 

 
26

 
763

 

 

 

 

Total securitized debt
(774
)
 
(15
)
 

 
26

 
763

 

 

 

 

Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees

 

 

 
(828
)
 

 

 

 

 
(828
)
Total guarantees

 

 

 
(828
)
 

 

 

 

 
(828
)
Total investments sold short, financial derivatives–liabilities, securitized debt, and guarantees, at fair value
$
(1,013
)
 
$
(17
)
 
$
2,611

 
$
(5,201
)
 
$
2,149

 
$
(4,688
)
 
$

 
$

 
$
(6,159
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2015, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2015. For Level 3 financial instruments held by the Company at December 31, 2015, change in net unrealized gain (loss) of $(20.7) million, $7 thousand, $(4.6) million, and $(0.8) million, for the year ended December 31, 2015 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
As of December 31, 2015, the Company transferred $48.5 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and/or similar assets. This increase in observed trading activity led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view.
In addition, as of December 31, 2015, the Company transferred $6.7 million of non-Agency RMBS from Level 2 to Level 3. Following December 2014, these securities exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities.
There were no transfers of financial instruments between Level 1 and Level 2 during the years ended December 31, 2017, 2016, and 2015.